Master California Supreme Court held that a physician's informed-consent duty includes disclosing material risks of refusing a recommended diagnostic test. with this comprehensive case brief.
Truman v. Thomas is a landmark California Supreme Court decision that extended the doctrine of informed consent beyond the risks of undergoing a proposed procedure to the material risks of refusing recommended diagnostic testing or treatment. Building on Cobbs v. Grant, the Court emphasized that the physician's duty to disclose is measured by the patient's informational needs, not by professional custom alone. In practical terms, the case obligates physicians to tell patients, in understandable terms, what could happen if they decline a recommended test—here, a Pap smear—when the undisclosed risk is material to a reasonable patient's decision.
For law students, Truman is essential because it broadens the scope of informed consent and clarifies causation and duty in medical malpractice where the harm arises from a patient's refusal of care. It also operates at the intersection of tort duty, patient autonomy, and professional responsibility, illustrating how courts balance respect for patient choice with the physician's obligation to communicate risk. The decision shapes jury instructions, office practices (including documentation of refusals), and the analysis of materiality and causation under the objective patient standard.
Truman v. Thomas, 27 Cal. 3d 285, 165 Cal. Rptr. 308, 611 P.2d 902 (Cal. 1980)
The decedent, Mrs. Truman, received routine medical care from Dr. Thomas over several years. During these visits, Dr. Thomas recommended that she undergo a Pap smear, a relatively simple and low-cost screening test for cervical cancer. Mrs. Truman declined the test on multiple occasions; reasons mentioned included cost and an apparent belief that it was unnecessary. Despite her refusals, Dr. Thomas did not inform her of the material risks associated with forgoing a Pap smear—specifically, that cervical cancer can be asymptomatic in early stages, that the Pap test is designed to detect precancerous changes and early cancer, and that untreated cervical cancer can be fatal. Mrs. Truman later developed advanced cervical cancer and died. Her survivors sued Dr. Thomas for wrongful death and medical malpractice on an informed-consent theory, contending that he breached his duty by failing to disclose the risks of refusing the recommended diagnostic test and that, had she been adequately informed, she would likely have consented to the Pap smear in time to prevent or mitigate the cancer. At trial, the court declined to instruct the jury that a physician's duty of informed consent includes disclosure of the risks of non-treatment or non-testing, and the defense prevailed. The Court of Appeal affirmed. The California Supreme Court granted review.
Does a physician's duty of informed consent encompass a duty to disclose the material risks inherent in a patient's refusal to undergo a recommended diagnostic test or treatment?
Under California's informed-consent doctrine (as articulated in Cobbs v. Grant), a physician has a duty to disclose all information material to a patient's decision to accept or reject a proposed procedure, which includes the nature and purpose of the intervention, the risks and benefits, and available alternatives. Materiality is measured by the objective patient standard: a risk is material if a reasonable person in the patient's position would consider it significant in deciding whether to proceed. This duty extends to disclosing the material risks of declining or delaying a recommended diagnostic test or treatment. Recognized exceptions include emergencies, situations where disclosure would be detrimental to the patient's well-being (therapeutic privilege), cases in which the patient already knows or specifically waives the information, or where the risk is so remote or obvious that disclosure is unnecessary. Causation in informed-consent cases is assessed by asking whether a reasonable patient, properly informed, would have consented to the recommended test or treatment.
Yes. A physician's informed-consent duty includes the obligation to disclose material risks of refusing a recommended diagnostic test or treatment. The trial court erred by failing to so instruct the jury. The judgment in favor of the defendant was reversed and the case remanded for a new trial under the proper legal standard.
The Court grounded its analysis in Cobbs v. Grant, which reoriented informed consent around patient autonomy and the materiality standard. The same patient-centered rationale applies when a physician recommends a diagnostic test: the patient's choice is meaningful only if made with an understanding of both the risks of proceeding and the risks of not proceeding. Because a reasonable person could not weigh the decision without knowing the potential consequences of refusal, nondisclosure of those consequences breaches the duty of informed consent where the undisclosed risks are material. The Court emphasized that it is not enough for a physician merely to recommend a test; the physician must explain, in terms the patient can grasp, what could happen if the test is refused, including the nature and gravity of the risk (here, the possibility of undetected cervical cancer and death) and the likely benefits of early detection. The Court rejected a custom-based limitation on the duty, noting that materiality is measured by the reasonable patient's informational needs, not by whether other physicians commonly give such warnings. On causation, the Court reaffirmed the objective standard: the trier of fact asks whether a reasonable patient in the decedent's position would have consented to the Pap smear had she been informed of the material risks of refusal. The physician's potential defenses—such as emergency, therapeutic privilege, patient waiver, or trivial/obvious risk—did not excuse the failure to warn in this context. Because the jury was not properly instructed that the duty of informed consent includes disclosure of the risks of nontreatment, the verdict could not stand and a new trial was required.
Truman v. Thomas is frequently taught with Cobbs v. Grant to show the full scope of informed consent: physicians must disclose material information not only about the procedure and alternatives but also about the consequences of refusal. For practitioners, it underscores the need to communicate clearly and document informed refusals. For students, it illustrates how tort law uses the objective patient standard to define both duty and causation in informed-consent claims and how doctrinal expansion (from procedure-focused disclosure to non-treatment risks) serves patient autonomy and risk management in clinical settings.
Cobbs established that physicians must disclose material information about proposed treatments based on the reasonable patient's needs. Truman extends that duty to material risks of refusing recommended diagnostic tests or treatments. The expansion ensures patients can compare the risks of proceeding versus not proceeding, making their choice truly informed.
A risk is material if a reasonable person in the patient's position would likely consider it important to the decision. For a Pap smear, the material risks of refusal include the possibility that asymptomatic cervical cancer or precancerous changes will go undetected, reducing survival prospects. The precise probability need not be quantified if the gravity and likelihood are significant enough to influence a reasonable patient's choice.
No. Truman preserves patient autonomy. Physicians must disclose material risks of refusal in understandable terms and answer questions. If the patient still refuses after adequate disclosure, the physician may document the informed refusal and continue care as appropriate or consider referral or withdrawal consistent with professional and legal obligations.
Causation uses the objective patient standard: the plaintiff must show that a reasonable person in the patient's position would have consented to the recommended test if properly informed of the material risks of refusal. Subjective testimony from the patient (or survivors) can be relevant, but the ultimate test is what a reasonable patient would have done.
Yes. As with other informed-consent duties, exceptions include emergencies where immediate action is necessary, situations in which disclosure would seriously harm the patient's well-being (therapeutic privilege), where the patient already knows the information or waives disclosure, and where the risk is trivial or obvious. These exceptions are narrow and fact-specific.
Physicians should explain in plain language why a test is recommended, the benefits of early detection, and the material risks of refusing. They should invite questions, assess understanding, and document the discussion and any refusal (often via a signed refusal form). They should also consider appropriate follow-up or referral if refusal persists.
Truman v. Thomas cements the principle that patient autonomy requires disclosure of material risks on both sides of the decision tree—undergoing a proposed intervention and refusing it. By tying the scope of disclosure to what a reasonable patient needs to know, the Court ensured informed consent functions as a meaningful, patient-centered doctrine rather than a narrow procedural formality.
For law students, Truman is a core case in medical malpractice and informed consent. It clarifies duty, materiality, and causation, influences jury instructions, and signals best practices for clinicians. It is both a doctrinal milestone and a practical guidepost for aligning medical communication with legal standards of patient-centered care.
Need to cite this case?
Generate a perfectly formatted Bluebook citation in seconds.
Use our Bluebook Citation Generator →